TABLE 1.
β-Lactam(s)b | MIC (μg/ml) for:
|
|||
---|---|---|---|---|
B. bronchiseptica DOR | B. parapertussis CIP 63.33a | E. coli DH10B (pFL-1)a | E. coli DH10B | |
Amoxicillin | 8 | 2 | 512 | 2 |
Amoxicillin + CLA | 2 | 0.12 | 8 | 2 |
Ticarcillin | 8 | 2 | 512 | 1 |
Ticarcillin + CLA | 2 | <0.06 | 64 | 1 |
Piperacillin | 0.25 | <0.06 | 8 | 1 |
Piperacillin + TZB | 0.06 | <0.06 | 4 | 1 |
Cephalothin | 8 | 8 | 4 | 2 |
Imipenem | 0.25 | 0.25 | 0.25 | 0.25 |
Cefoxitin | 512 | 64 | 2 | 2 |
Cefuroxime | 512 | 2 | 4 | 2 |
Cefotaxime | 512 | 0.5 | <0.06 | <0.06 |
Ceftazidime | 16 | <0.06 | <0.06 | <0.06 |
Cefepime | 16 | <0.06 | <0.06 | <0.06 |
Cefpirome | 512 | <0.06 | <0.06 | <0.06 |
Aztreonam | 512 | 0.06 | 0.06 | 0.06 |
Moxalactam | 1 | 0.12 | 0.12 | 0.12 |
B. parapertussis CIP 63.33 and E. coli DH10B (pFL-1) produced β-lactamase BOR-1.
CLA, clavulanic acid at a fixed concentration of 2 μg/ml; TZB, tazobactam at a fixed concentration of 4 μg/ml.